FDC Ltd. — Board/Management Information 2024

May 2, 2024

==> picture [452 x 83] intentionally omitted <==

Date:- May 02, 2024

To, BSE Limited National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra - Kurla Complex, Bandra (E), Mumbai- 400 001 Mumbai - 400 051 Scrip code- 531599 Symbol- FDC

Dear Sir / Madam,

Sub: Outcome of the Board meeting and disclosure under Regulation 30 of SEBI Listing and Obligations and Disclosure Requirement Requlation, 2015.

This is to inform you that the Board of Directors of FDC Limited (“the Company”) at their meeting held today i.e. on May 02, 2024:

1. Took note of the Completion of tenure of Independent Directors of the Company, namely, Ms. Usha Athreya Chandrasekhar and Mr. Melarkode Ganesan Parameswaran on May 9, 2024.

The Board of Directors of the Company placed on record their utmost appreciation and gratitude for the meaningful contribution made by Ms. Usha Athreya Chandrasekhar and Mr. Melarkode Ganesan Parmeswaran, during their tenure with the Company and wish them the best for future endeavours.

1. Approved the Re-appointment of Dr. Mahesh Bijlani (DIN:08447258) as a Non-Executive & Independent Director of the Company for the Second Term of 5 (Years) with effect from May 10, 2024 to May 09, 2029 based on the recommendation of the Nomination and Remuneration Committee and subject to the approval of the members of the Company.

Additional details pursuant to Regulation 30 and other relevant provisions of the SEBI Listing Regulations is enclosed as Annexure-A .

Kindly take the same on record. Thanking you, Yours truly, For FDC Limited VARSHARAN Digitally signed by VARSHARANI I RAJARAM RAJARAM KATRE KATRE Date: 2024.05.02 18:19:17 +05'30'

Varsharani Katre Company Secretary & Compliance Officer Membership no:- F8948

==> picture [452 x 85] intentionally omitted <==

==> picture [452 x 83] intentionally omitted <==

Annexure-A

Additional Details as required under Regulation 30 and other relevant provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015.

	Particulars	Ms. Usha Athreya Chandrasekhar	Mr. Melarkode Ganesan Parameswaran	Dr. Mahesh Bijlani
	Reason for Change viz. Appointment, Re- appointment~~/Resignation,~~ ~~removal, death or~~otherwise	Completion of Tenure of Appointment	Completion of Tenure of Appointment	Re-appointment
	Date of Appointment/ reappointment /cessation (as applicable) and term of appointment /reappointment	Completion on May 9, 2024	Completion on May 9, 2024	Re-appointment of Dr. Mahesh Bijlani (DIN: 08447258), as Non- Executive & Independent Director of the Company, for a second term of five years with effective from May 10, 2024 to May 09, 2029.
	Brief Profile (In case of Appointment)	Not Applicable	Not Applicable	Dr. Bijlani [MBBS, MS (Gen. Surgery), DNB (Gen. Surgery), FKAC (MIS) (Germany)] is a Medical Practitioner by profession for more than 30 years, having vast experience in the field of laparoscopic Surgery, Bariatric Surgery and General Medication. Dr. Bijlani is associated with Indian Medical Association, Association of Surgeons, International Hepatobiliary Pancreatic Association, and Bandra Khar Medical Association.

==> picture [452 x 85] intentionally omitted <==

==> picture [452 x 83] intentionally omitted <==

Disclosure of Relationship between directors (In case of Appointment of a Director)	Not Applicable	Not Applicable	Dr. Mahesh Bijlani is not related to any of the Directors of the Company.
Information as required pursuant to BSE circular ref no. LIST/ COMP/ 14/ 2018- 19 and the National Stock Exchange of India Limited dated June 20,2018	Not Applicable	Not Applicable	Dr. Mahesh Bijlani is not Debarred from holding office of a Director by Virtue of any SEBI order or any other such Authority.

==> picture [452 x 85] intentionally omitted <==